NDC 65219-822 – Otulfi
Ustekinumab 45 mg/.5mL · Injection, Solution · Subcutaneous
Product NDC65219-822
Product details
- Brand name
- Otulfi
- Generic name
- Ustekinumab-aauz
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761379
- Marketed since
- September 29, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- Interleukin-12 Antagonist; Interleukin-23 Antagonist
Active ingredients
- Ustekinumab 45 mg/.5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 65219-822-05 | 1 VIAL in 1 CARTON (65219-822-05) / .5 mL in 1 VIAL | Sep 29, 2025 |